Mobility Skills with Exoskeletal-Assisted Walking in Persons with Sci: Results from a Three Center Randomized Clinical Trial
A randomized clinical trial was conducted across three sites, in persons with chronic non-ambulatory SCI. The primary aim was to determine the number of sessions necessary to achieve adequate Exoskeleton Assisted Walking skills and velocity milestones. A total of 50 participants completed 36 sessions with ReWalk and Ekso devices. At 12 sessions 62%, 70%, and 72% of participants achieved the 10MWT, 6MWT, and TUG milestones, respectively. By 36 sessions 80%, 82%, and 84% achieved the 10MWT, 6MWT, and TUG milestones, respectively. The researchers concluded that it is feasible to train chronic non-ambulatory individuals with SCI in performance of Exoskeleton assisted walking sufficiently to achieve reasonable mobility skill outcome milestones.
Reach us here to learn more about the ReWalk Personal Exoskeleton.
If you click on one of the icons listed here, your personal data will be transmitted to the selected network.